Here are five notes:
1. In February, K2M’s short interest totaled 949,400 shares.
2. Short sellers will need five days to cover their K2M’s short positions.
3. On Feb. 12, the stock increased 1.37 percent to $11.88.
4. Since July 10, 2015, K2M has decreased 48.93 percent.
5. K2M has underperformed the S&P500 by 38.72 percent.
More articles on devices:
Mesoblast cell therapy shows positive results for patients with rheumatoid arthritis — 5 points
Smith & Nephew target of a large growth in short interest — 4 observations
43 spine, orthopedic devices receive FDA 510(k) clearance in January
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
